» Articles » PMID: 34771466

The Incidence of Bacteremia and Risk Factors of Post-Radiofrequency Ablation Fever for Patients with Hepato-Cellular Carcinoma

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2021 Nov 13
PMID 34771466
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Post-radiofrequency ablation (RFA) fever is a self-limited complication of RFA. The correlation between post-RFA fever and bacteremia and the risk factors associated with post-RFA fever have not been evaluated. Patients with newly diagnosed or recurrent hepatocellular carcinoma who underwent ultrasonography-guided RFA between April 2014 and February 2019 were retrospectively enrolled. Post-RFA fever was defined as any episode of body temperature >38.0 °C after RFA during hospitalization. A total of 272 patients were enrolled, and there were 452 applications of RFA. The frequency of post-RFA fever was 18.4% (83/452), and 65.1% (54/83) of post-RFA fevers occurred on the first day after ablation. Patients with post-RFA fever had a longer hospital stay than those without (9.06 days vs. 5.50 days, < 0.001). Only four (4.8%) patients with post-RFA fever had bacteremia. The independent factors associated with post-RFA fever were younger age (adjusted odds ratio (OR) = 0.96, 95% CI, 0.94-0.99, = 0.019), low serum albumin level (adjusted OR = 0.49, 95% CI, 0.25-0.95, = 0.036), general anesthesia (adjusted OR = 2.06, 95% CI, 1.15-3.69, = 0.015), tumor size (adjusted OR = 1.52, 95% CI, 1.04-2.02, = 0.032), and tumor number (adjusted OR = 1.71, 95% CI, 1.20-2.45, = 0.003).

Citing Articles

Relationship between postablation fever and prognosis in initial hepatocellular carcinoma: a 15-year multicenter, retrospective cohort study.

Cai Q, Pang C, Wang Z, Li J, Dai Y, Fan F Int J Surg. 2024; 111(1):962-971.

PMID: 39291970 PMC: 11745605. DOI: 10.1097/JS9.0000000000002066.


Local Ablation for Hepatocellular Carcinoma: 2024 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association.

Han S, Sung P, Park S, Kim J, Hong H, Yoon J Gut Liver. 2024; 18(5):789-802.

PMID: 39223081 PMC: 11391139. DOI: 10.5009/gnl240350.


Local ablation for hepatocellular carcinoma: 2024 expert consensus-based practical recommendation of the Korean Liver Cancer Association.

Han S, Sung P, Park S, Kim J, Hong H, Yoon J J Liver Cancer. 2024; 24(2):131-144.

PMID: 39210668 PMC: 11449576. DOI: 10.17998/jlc.2024.08.04.


Local Ablation for Hepatocellular Carcinoma: 2024 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association.

Han S, Sung P, Park S, Kim J, Hong H, Yoon J Korean J Radiol. 2024; 25(9):773-787.

PMID: 39197823 PMC: 11361797. DOI: 10.3348/kjr.2024.0550.


Postoperative SIRS after thermal ablation of HCC: Risk factors and short-term prognosis.

Peng X, Xing J, Zou H, Pang M, Huang Q, Zhou S Heliyon. 2024; 10(3):e25443.

PMID: 38327471 PMC: 10847922. DOI: 10.1016/j.heliyon.2024.e25443.


References
1.
Chehab M, Thakor A, Tulin-Silver S, Connolly B, Cahill A, Ward T . Adult and Pediatric Antibiotic Prophylaxis during Vascular and IR Procedures: A Society of Interventional Radiology Practice Parameter Update Endorsed by the Cardiovascular and Interventional Radiological Society of Europe and the Canadian.... J Vasc Interv Radiol. 2018; 29(11):1483-1501.e2. DOI: 10.1016/j.jvir.2018.06.007. View

2.
Ohmoto K, Yoshioka N, Tomiyama Y, Shibata N, Kawase T, Yoshida K . Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas. J Gastroenterol Hepatol. 2008; 24(2):223-7. DOI: 10.1111/j.1440-1746.2008.05596.x. View

3.
Feng K, Yan J, Li X, Xia F, Ma K, Wang S . A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol. 2012; 57(4):794-802. DOI: 10.1016/j.jhep.2012.05.007. View

4.
Piccioni F, Poli A, Templeton L, Templeton T, Rispoli M, Vetrugno L . Anesthesia for Percutaneous Radiofrequency Tumor Ablation (PRFA): A Review of Current Practice and Techniques. Local Reg Anesth. 2019; 12:127-137. PMC: 6900282. DOI: 10.2147/LRA.S185765. View

5.
Zhang L, Wang N, Shen Q, Cheng W, Qian G . Therapeutic efficacy of percutaneous radiofrequency ablation versus microwave ablation for hepatocellular carcinoma. PLoS One. 2013; 8(10):e76119. PMC: 3798302. DOI: 10.1371/journal.pone.0076119. View